Literature DB >> 29630125

Effects of sevoflurane post-conditioning in cerebral ischemia-reperfusion injury via TLR4/NF-κB pathway in rats.

C-X Shi1, Y-B Ding, F Yu J Jin, T Li, J-H Ma, L-Y Qiao, W-Z Pan, K-Z Li.   

Abstract

OBJECTIVE: The aim of the study was to investigate the anti-inflammatory effect of sevoflurane post-conditioning on cerebral ischemia-reperfusion injury in rats.
MATERIALS AND METHODS: Thirty Sprague Dawley (SD) rats were randomly divided into 3 groups: sham operation group (Sham), ischemia/reperfusion injury (I/R) group and sevoflurane post-conditioning group (Se). Hematoxylin-eosin (HE) staining was used to observe the inflammatory response in the brain tissue. The levels of TNF-α, IL-1β, IL-6 in serum were measured by ELISA. The mRNA and protein expression of TLR4 and NF-κB p65 were detected by RT-PCR and Western blot in the brain tissue.
RESULTS: The post-conditioning of sevoflurane decreased the level of inflammatory reaction in ischemic-reperfusion rat cerebral infarction area and reduced the levels of pro-inflammatory cytokines such as TNF-α, IL-1β, IL-6 in rats with ischemia-reperfusion injury. In addition, after treatment with sevoflurane, the mRNA and protein expression of TLR4 and NF-κBp65 in TLR4/NF-κB pathway was inhibited.
CONCLUSIONS: Sevoflurane post-conditioning can decrease the inflammatory reaction in cerebral infarct area induced by cerebral ischemia-reperfusion injury in rats. The neuroprotective effect mechanism of sevoflurane may be related to TLR4/NF-κB signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29630125     DOI: 10.26355/eurrev_201803_14595

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  8 in total

1.  Modifications of gene expression detected in peripheral blood after brain ischemia treated with remote postconditioning.

Authors:  Marek Furman; Miroslava Nemethova; Lubica Macakova; Vladimir Sihotsky; Ivan Kopolovets; Peter Berek; Michal Virag; Rastislav Mucha
Journal:  Mol Biol Rep       Date:  2021-11-12       Impact factor: 2.316

2.  Neuroprotective, Anti-inflammatory Effect of Furanochrome, Visnagin Against Middle Cerebral Ischemia-Induced Rat Model.

Authors:  Qiangyuan Tian; Hua Yin; Jisen Li; Jinggong Jiang; Binbin Ren; Junhui Liu
Journal:  Appl Biochem Biotechnol       Date:  2022-07-11       Impact factor: 3.094

Review 3.  miRNA Involvement in Cerebral Ischemia-Reperfusion Injury.

Authors:  Maria-Adriana Neag; Andrei-Otto Mitre; Codrin-Constantin Burlacu; Andreea-Ioana Inceu; Carina Mihu; Carmen-Stanca Melincovici; Marius Bichescu; Anca-Dana Buzoianu
Journal:  Front Neurosci       Date:  2022-06-10       Impact factor: 5.152

4.  Anti-Neuroinflammatory Effect of Alantolactone through the Suppression of the NF-κB and MAPK Signaling Pathways.

Authors:  Liwei Tan; Jinsheng Li; Yeye Wang; Rui Tan
Journal:  Cells       Date:  2019-07-18       Impact factor: 6.600

5.  Sevoflurane attenuates brain damage through inhibiting autophagy and apoptosis in cerebral ischemia‑reperfusion rats.

Authors:  Cun-Xian Shi; Jin Jin; Xue-Qin Wang; Teng Song; Guang-Hong Li; Ke-Zhong Li; Jia-Hai Ma
Journal:  Mol Med Rep       Date:  2019-11-20       Impact factor: 2.952

6.  MicroRNA-579-3p Exerts Neuroprotective Effects Against Ischemic Stroke via Anti-Inflammation and Anti-Apoptosis.

Authors:  Jiaoying Jia; Yan Cui; Zhigang Tan; Wenjia Ma; Yugang Jiang
Journal:  Neuropsychiatr Dis Treat       Date:  2020-05-12       Impact factor: 2.570

Review 7.  Nanomedicine and graphene-based materials: advanced technologies for potential treatments of diseases in the developing nervous system.

Authors:  Giada Cellot; Audrey Franceschi Biagioni; Laura Ballerini
Journal:  Pediatr Res       Date:  2021-09-03       Impact factor: 3.953

8.  Role of microRNA‑218‑5p in sevoflurane‑induced protective effects in hepatic ischemia/reperfusion injury mice by regulating GAB2/PI3K/AKT pathway.

Authors:  Hui Ji; Hui Li; Haixia Zhang; Zhijun Cheng
Journal:  Mol Med Rep       Date:  2021-11-02       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.